Product Description
This digital document is an article from BIOTECH Patent News, published by Thomson Gale on August 1, 2005. The length of the article is 773 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: DOR BioPharma and Dowpharma enter into a joint development agreement for oral vaccine against botulinum toxin poisoning.Publication: BIOTECH Patent News (Newsletter)Date: August 1, 2005Publisher: Thomson GaleVolume: 19 Issue: 8Distributed by Thomson Gale